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Abstract 
Scrapie and bovine spongiform encephalopathy (BSE) are transmissible spongiform encephalopathies (TSE’s) affect‑
ing sheep and goats. Susceptibility of goats to scrapie is influenced by polymorphisms of the prion protein gene 
(PRNP) of the host. Five polymorphisms are associated with reduced susceptibility to TSE’s. In the study presented 
here caprine samples from a scrapie eradication program on Cyprus were genotyped and further characterized using 
BioRad TeSeE rapid test, histological, immunohistochemical and biochemical methods. In total 42 goats from 20 flocks 
were necropsied from which 25 goats showed a positive result in the rapid test, a spongiform encephalopathy and 
an accumulation of pathological prion protein (PrPSc) in the obex. PrPSc deposits were demonstrated in the placenta, 
peripheral nervous and lymphoreticular system. Two animals showed PrPSc‑accumulations in peripheral tissues only. 
By discriminatory immunoblots a scrapie infection could be confirmed for all cases. Nevertheless, slight deviations in 
the glycosylation pattern might indicate the presence of different scrapie strains. Furthermore scrapie samples from 
goats in the current study demonstrated less long term resistance to proteinase K than ovine or caprine BSE con‑
trol samples. Reduced scrapie susceptibility according to the PRNP genotype was demonstrated (Fishers Exact test, 
p < 0.05) for the goats with at least one polymorphism (p = 0.023) at the six codons examined and in particular for 
those with polymorphisms at codon 146 (p = 0.016). This work characterizes scrapie in goats having implications for 
breeding and surveillance strategies.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Transmissible spongiform encephalopathies (TSE’s) are 
progressive, fatal neurodegenerative diseases in humans 
and mammals. Causative is the conversion of the cellu-
lar membrane bound prion protein (PrPc) into a partially 
protease-resistant pathologic form (PrPSc) [1]. TSE’s 
are characterized by long incubation periods of several 
months or even years. Among others, there is scrapie in 
sheep, goats and mufflons [2–4] and also bovine spongi-
form encephalopathy which was first described in cattle 
in 1986 [5] being the only animal prion disease confirmed 
to affect human beings (Creutzfeldt–Jakob disease) and 
mammals [6].
The first natural caprine scrapie case was not reported 
before 1942 [2], and, apart from diverse outbreaks in 
cattle, natural BSE infection was only diagnosed in one 
single British goat in 2005 [7]. Later on, a Scottish goat 
with BSE disease from 1990 was revealed in retrospec-
tive studies in the United Kingdom [8]. To date, natural 
BSE was never detected in sheep though the disease was 
successfully transmitted to sheep and goats under experi-
mental conditions [9]. As already described for sheep, 
the susceptibility of goats for scrapie is highly influenced 
by polymorphisms of the prion protein gene (PRNP). To 
date, more than 40 polymorphisms of the caprine PRNP 
have been described in different countries and breeds 
[10–14]. Among these, only five polymorphisms were 
found which seem to correlate with TSE susceptibility. 
The polymorphisms I142M and R154H extend incuba-
tion period and for the latter partially protective effects 
had been described [12, 13, 15, 16]. Effects on resistance 
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against TSE were associated with the polymorphisms 
N146S/D, R211Q and Q222K polymorphisms [12, 13, 17, 
18].
As described for sheep, goats are typically diagnosed 
with scrapie at the age of 3 to 4  years [19], and clinical 
signs last from 2  weeks to 6  months [19–21]. Apathy, 
ataxia, severe pruritus, difficulties in milking and loss of 
weight are clinical signs seen in affected goats [20]. For 
sheep it is known that scrapie is transmitted horizon-
tally under natural conditions via direct contact or from 
contaminated environment [22, 23]. The oral route is the 
most efficient entrance for the TSE material and the pla-
centa after birth is the main source of infection [24–26]. 
However, PrPSc and/or infectivity have also been found in 
amniotic fluid [26], faeces [27], milk [28, 29] and even in 
the oral cavity of scrapie infected sheep [30]. Scrapie in 
goats is often found in mixed herds together with sheep 
[2, 31], but it has also been observed to spread from goat 
to goat [19].
Pathogenesis of scrapie has been widely described 
in sheep and to a lesser extent in goats. In sheep, first 
accumulations of PrPSc can be immunohistochemically 
detected in the tonsils and the gut associated lymphatic 
tissue such as the Peyers’ patches of the ileum and jeju-
num after oral ingestion [32–34].
Later on, PrPSc spreads and accumulates in the corre-
sponding mesenteric lymph nodes [33, 35, 36] as well as 
in peripheral lymph nodes and the spleen [35, 37]. PrPSc 
deposits were also detected in the enteric nervous system 
with duodenum and ileum as first positive sites and with 
the tendency to spread extensively in the cranial and cau-
dal parts of the ENS [32, 33]. It is widely accepted that 
PrPSc ascends along the parasympathetic and/or sympa-
thetic nerve fibres with finally reaching the brain and the 
spinal cord, respectively [32]. As an additional pathway 
the hematogenous distribution of PrPSc is discussed con-
sidering PrPSc infectivity which was found in ovine blood 
[38] as well as the infection of the brain via circumven-
tricular organs [39]. Studies describing natural scrapie 
in goats are rare but the data known so far indicate that 
the spread of PrPSc is comparable to classical scrapie in 
sheep [40–43]. However there can be a distinct variabil-
ity among individual animals, which, among other things, 
might be due to a high variability of classical scrapie 
strains and their interactions with the particular geno-
type of the host [41].
Scrapie is spread nearly worldwide in sheep and goats 
[10, 31, 44, 45]. In Cyprus, scrapie has been a major prob-
lem for animal husbandry since the first detection in 1985 
[31]. Thus within the European Union between 2007 and 
2009, about 90% of the positive goat scrapie cases were 
found in Cyprus [41]. The applied extensive eradication 
programs were a unique possibility to collect samples 
from goats which were naturally infected with scrapie.
The study presented here describes a biochemical 
and immunohistochemical characterization of natural 
goat scrapie cases including PRNP genetics. It is aimed 
to shed more light on the pathogenesis of this disease 
in goats and also to characterize the diversity of natural 
scrapie strains on Cyprus more precisely excluding pos-
sible BSE cases at the same time.
Materials and methods
Animals
The goats were chosen within the framework of a scra-
pie eradication program that has been implemented 
in Cyprus. All animals were killed in accordance to the 
European animal welfare regulations. In total 42 Cypriot 
female goats of a local Damascus breed that were show-
ing scrapie like clinical signs (alopecia, cachexia and/or 
ataxia) were sourced out from twenty flocks of the Nico-
sia district. Afterwards these goats of different ages were 
dissected in the facilities of the Veterinary Services (VS), 
Ministry of Agriculture, Rural Development and Envi-
ronment, 1417 Nicosia, Cyprus. Beside blood samples a 
wide range of frozen and formalin fixed tissue samples 
were taken under TSE sterile conditions. All the 42 goats 
were kept together with sheep or were kept on pastures 
which formerly used sheep for grazing. Data of all goats 
are given in Tables 1 and 2.
Genotyping
The genotyping of the codons 142, 146, 151, 154, 211 and 
222 of the prion protein gene (PRNP) was done by C. H. 
Panagiotidis at the Aristotle University in Thessaloniki 
Greece using the cycle-sequencing method formerly 
described [46].
Tissue samples
Selected tissue samples were examined following differ-
ent analysis procedures (Figure  1). Brain stem material 
(obex region) of all 42 goats was examined histologically, 
immunohistochemically and biochemically. Further sam-
ples were examined immunohistochemically only. In this 
case, to limit the samples sizes which had to be examined, 
the most likely sites of PrPSc accumulations such as the 
retropharyngeal lymph node, tonsils, third eye lid, spleen, 
celiac and mesenteric ganglion complex (CMGC) and 
rectum of all goats were examined in a first step. In a sec-
ond step, samples of the kidney, mammary gland, uterus 
and, if available, placentomal tissue of the placenta were 
examined with only taking the goats into account which 
revealed PrPSc positive results in the tissue samples ana-
lysed previously.
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Histology and immunohistochemistry
The tissue samples as well as the resulting sections were 
treated as described before [47] with following modifica-
tions. Sections were cut in serials by producing sections 
of up to three areas per paraffin block. The three areas 
were chosen in a 25–30 µm distance what guaranteed a 
totally different cell layer in each area examined. Sections 
of all samples were stained with haematoxylin and eosin. 
For the detection of caprine PrPSc, the three different 
PrP-specific monoclonal antibodies (mAb) 6C2 (Central 
Veterinary Institute of Wageningen UR, Lelystad, Neth-
erlands), F99 (VMRD, Pullman, USA) and L42 [48] 
which were raised to the epitope 114–120 of bovine PrP 
protein (6C2) and to epitop 220–225 (F99) and epitop 
145–163 (L42) of ovine PrP protein, respectively, were 
chosen. Before applying the antibodies, the sections had 
been pre-treated by incubation for 30 min (6C2, F99) or 
15 min (L42) in 98% formic acid and rinsed in tap water 
for 5 min. After inhibiting the endogenous Peroxidase the 
sections had been autoclaved in citrate buffer for 20 min 
Table 2 Data and results of all scrapie negative Damascus goats from Cyprus
D: aspartic acid; I: isoleucine; H: histidine; M: methionine; N: asparagine; Q: glutamine; R: arginine; S: serine; A–T: goat herds; age is given in years; Cut-off BioRad rapid 
test: 0.213; IHC: immunohistochemistry; +, ++, +++: mild, moderate, severe PrPSc accumulation (the first number indicates the number of positive follicles, the 
second number the total number of follicles examined); CMGC: celiac and mesenteric ganglion complex; Ln. retroph.: retropharyngeal lymph node; 0: no lymphatic 
follicles; ENS: enteric nervous system; neg.: PrPSc negative; NA tissue sample not available.
Goat ZYP Flock (age) Brain stem CM GC Ln. retroph. Tonsil 3rd eye lid Spleen Rectum Placenta
IHC (rapid test) Follicles ENS
I142N146R151R154R211Q222
6 A (7) neg. (0.014) neg. neg. 0/120 neg. 0/45 neg. 0/13 neg. 0/231 NA NA NA
18 H (4) neg. (0.016) neg. neg. 0/97 neg. 0/111 neg. 0/21 neg. 0/3741 neg. 0/9 neg. NA
23 K (6) neg. (0.011) neg. neg. 0/110 neg. 0/64 neg. 0/3 neg. 0/201 neg. 0/116 neg. NA
32 O (4) neg. (0.018) neg. neg. 0/401 0 neg. 0/9 neg. 0/173 neg. 0/47 neg. NA
38 Q (3) neg. (0.010) neg. neg. 0/217 neg. 0/186 0 neg. 0/276 neg. 0/49 neg. NA
42 S (2) neg. (0.007) neg. neg. 0/388 neg. 0/149 neg. 0/1 neg. 0/345 neg. 0/5 neg. neg.
43 S (3) neg. (0.008) neg. neg. 0/98 neg. 0/2 neg. 0/39 neg. 0/313 neg. 0/35 neg. neg.
44 S (4) neg. (0.008) neg. neg. 0/329 neg. 0/73 neg. 0/26 neg. 0/306 neg. 0/46 neg. NA
45 T (5) neg. (0.010) neg. neg. 0/359 neg. 0/132 neg. 0/4 neg. 0/223 neg. 0/16 neg. NA
46 T (4) neg. (0.010) neg. neg. 0/548 neg. 0/195 neg. 0/51 neg. 0/294 neg. 0/14 neg. NA
N/S146
2 A (7) neg. (0.017) neg. neg. 0/219 neg. 0/86 neg. 0/1 neg. 0/267 neg. 0/1 neg. NA
S146
4 A (7) neg. (0.049) neg. neg. 0/230 neg. 0/158 0 neg. 0/106 neg. 0/2 neg. NA
N/D146
28 M (2) neg. (0.010) neg. neg. 0/223 neg. 0/204 neg. 0/18 neg. 0/207 neg. 0/31 neg. NA
M142
36 Q (3) neg. (0.010) neg. neg. 0/131 neg. 0/49 neg. 0/3 neg. 0/270 neg. 0/2 neg. NA
N/D146R/H151
39 Q (4) neg. (0.007) neg. neg. 0/899 neg. 0/2 neg. 0/21 neg. 0/168 neg. 0/3 neg. neg.
D: aspartic acid; I: isoleucine; H: histidine; M: methionine; N: asparagine; Q: glutamine; R: arginine; S: serine; A–T: goat herds; age: is given in years; Cut-off BioRad rapid 
test: 0.213; IHC: immunohistochemistry; +, ++, +++: mild, moderate, severe PrPSc accumulation (the first number indicates the number of positive follicles, the 
second number the total number of follicles examined); CMGC: celiac and mesenteric ganglion complex; Ln. retroph.: retropharyngeal lymph node; 0: no lymphatic 
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at 121 °C and 3 bar (6C2, F99) or pre-treated by protein-
ase K (PK, 4  µg/mL) digestion (L42). The primary anti-
bodies were applied at a dilution of 1:50 up to 1:150 (6C2) 
depending on the stock concentration and 1:10 000 (F99) 
or 1:250 (L42) in goat serum including 0.03% sodium 
azide and incubated for 2  h at room temperature. The 
process was finished as described by [47].
Rapid testing and biochemical methods
Brain stem material of all necropsied goats was primar-
ily analysed in the TSE Section of the Laboratory of Ani-
mal Health (LAH) of VS by applying the BioRad TeSeE 
(München, Germany) rapid test in line with the manual 
instructions. Optical density (OD) values more than 
twofold above the cut-off were defined as clear reactive 
samples.
The identified TSE-positive samples and BSE and 
scrapie references were additionally analyzed in the dis-
criminatory immunoblot, the so called FLI-test. The lat-
ter included a phosphotungic acid (PTA) precipitation 
of PrPSc followed by SDS-PAGE and immunoblotting, as 
described before [49] with the following modifications: In 
general, a 100 µL-aliquot of brain homogenates was sub-
jected to precipitation. However, depending on the con-
tent of PrPSc and the resulting signal intensity obtained 
from the immunoblot, the volume of brain homogenate 
varied from 30 µL up to 200 µL. A second precipitation 
step was included to optimize the original PTA precipita-
tion protocol. First, the resulting pellet was homogenized 
in 45  µL of 50  mM Citrate buffer (pH 6.0/NaOH) con-
taining 200 mM KCl, 5.0 mM MgCl2 and 1.25% (w/v) sar-
cosine. A volume of 0.5 µL of thyroglobulin, suspended 
in bi-distilled water (5  mg/mL), was added followed by 
vortexing in 500 µL of methanol (99.8%) and storage at 
−20  °C for at least 1 h. After centrifugation for 30 min, 
the supernatant was removed and the pellet was dried 
under constant shaking at 37 °C. All centrifugation steps 
were carried out at 17 000 g. Finally the pellet was sus-
pended in a sample buffer for SDS-PAGE as described 
before [51]. The two antibodies mAb L42 and the mAb 
P4 (R-Biopharm) were selected. As standard marker 
the FLI-marker was used [50]. Banding patterns were 
Figure 1 Schema of immunohistochemical and biochemical tests carried out on selected samples of the Cypriot goats. At first, brain 
stem samples of all 42 goats were examined by different methods. Subsequently the most likely sites of PrPSc accumulations such as the ret‑
ropharyngeal lymph node, tonsils, third eye lid, spleen, celiac and mesenteric ganglion complex (CMGC) and rectum of all goats were examined 
by immunohistochemistry (I). In a second step, samples of the kidney, mammary gland, uterus and, if available, placentomal tissue of the placenta 
were examined with only taking the goats into account which revealed PrPSc positive results in the tissue samples analysed previously (II). Addition‑
ally all positive brain stem samples were examined by discriminatory immunoblot.
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revealed using the chemiluminescence substrate CDP-
Star (Tropix, USA). After incubation for 5 min, emitted 
light signals were recorded by a photo imager system 
(Versadoc, Bio-Rad, Germany). Positive controls such 
as classical ovine scrapie and bovine BSE brain mate-
rial were included in each assay. Molecular masses were 
assessed by concurrent FLI-marker [50] and determined 
by the analysis software Quantity One (BioRad, Ger-
many). The values were calculated as mean  ±  SD of at 
least four independent determinations.
The FLI-test identifies the different cleavage sites of 
the PK for BSE and scrapie which are varying between 
the amino acids 96 to 97 and between the amino acids 
81 to 89, respectively. Thus, the persisting PrPSc frag-
ments of BSE are smaller than those of the most scrapie 
PrPSc fragments after the PK digestion. To discriminate 
BSE from scrapie three parameters have to be met as 
described elsewhere [49]. The molecular weight of the 
un-glycosylated form of the PrPSc has to be compared 
with the un-glycosylated form of the PrPSc of a positive 
scrapie control. A BSE isolate shows a lower molecu-
lar weight than the scrapie control (of >0.5 kDa). In the 
immunoblot, the PrPSc fragments are visualized using 
antibody binding sites either at the PrP core region (mAb 
L42) or at an N-terminal site, which is still present in PK 
treated PrPSc (mAb P4) of scrapie, but removed in that 
of BSE. Therefore the mAb P4 binds to the PrPSc of BSE 
only weakly or does not bind at all, which results in a 
P4/L42 binding ratio of <0.4. The epitope specificities of 
these antibodies have been shown earlier [51]. Finally, 
following the glycosylation pattern of the PrPSc, samples 
are BSE-like when showing a percentage of the diglyco-
sylated form of the total PrPSc signal of >50.0%.
Analysis of long‑term proteinase K (PK) resistance
Long term resistance against proteolysis with protein-
ase K was determined for five selected isolates after 48 h 
exposure. A 600 µL-aliquot of equally homogenized brain 
material, diluted with phosphate buffered saline (PBS) to 
a final concentration of 20 mM, was adjusted with mag-
nesium chloride to a final concentration of 1  mM and 
with benzonase to a final concentration of 50 U/mL and 
incubated with PK (final concentration 100  µg/mL) at 
55  °C and under continuous shaking. After 1, 6, 24 and 
48 h of proteolysis, 150 µL each was taken for PTA pre-
cipitation of PrPSc, which was done without heat dena-
turizing at 95  °C for 5 min, followed by SDS-PAGE and 
immunoblotting and photo imaging as for the FLI-test 
[49]. The test to determine long term PK resistance was 
repeated four times for each sample and data were given 
as the mean of the four independent determinations.
Controls, references and comparative samples
Control and positive reference material for immunohis-
tochemical and biochemical examinations was taken 
from ovine, caprine or bovine brain stem samples which 
had been tested scrapie and BSE-negative or scrapie and 
BSE-positive, respectively, from the national reference 
laboratory for transmissible spongiform encephalopathy 
of the Friedrich–Loeffler Institute (FLI), Isle of Riems, 
Germany. As comparative samples for biochemical exam-
inations were additionally used BSE-positive brain stem 
materials, experimental generated in sheep (486; Frederic 
Lantier, INRA, France) and goat (ZG01; FLI, Germany) 
and one single scrapie-positive (Stdl. 171) as well as one 
single bovine sample (R 8/09), which had been submitted 
for diagnostic purposes to the FLI before.
Statistical analysis
The statistical analysis was done using the exact Fisher 
test taking into account a maximum error probability 
of 5% (α =  5%). Consequently, differences [between the 
results (p)] were only labeled statistically significant with 
a p smaller 0.05 (p  <  0.05). Statistical calculation was 
done using R version 2.8.1 (2008).
Results
The 42 goats which were sourced from the different herds 
due to scrapie-like clinical signs like alopecia, cachexia 
and ataxia were tested by BioRad TeSeE rapid test imme-
diately after necropsy. Twenty-five of the samples were 
tested PrPSc reactive with OD values between 1.069 and 
2.204 (cut-off  =  0.213) and 17 samples showed clearly 
negative results with OD values between 0.007 and 0.049 
(cut off = 0.213). The rapid test results were confirmed by 
immunohistochemistry using mAb 6C2.
The TSE positive goats exhibited the I142N146R-
151R154R211Q222 genotype (wild-type) with one exception 
(goat ZYP40) that showed a polymorphism at codon 154 
(R154H). The goats were two (n = 2), three (n = 5), five 
(n = 2), six years (n = 1) and most of them four years old 
(n = 15). The variability of genotypes was higher among 
the TSE negative goats, exhibiting in four animals single 
polymorphisms as N146S (n = 1), S146S (n = 1), N146D 
(n =  1) and M142  M (n =  1), respectively. In addition, 
one goat revealed a N146D and a R151H polymorphism 
at the same time. Again, most of the TSE negative goats 
were four years old (n  =  5), and four goats had been 
3 years old. The remaining TSE negative goats were two 
(n =  3), five to six (n =  1 each) or 7  years old (n =  3), 
which points to a greater number of the younger and the 
older goats. The compilation of all data can be seen in 
Tables 1 and 2.
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Biochemical characterization
Brain stem samples of the 25 as PrPSc positive identi-
fied goats were further characterized using the FLI test. 
Therein, the glycosylation pattern, the percentage of 
the di-glycosylated form of the PrPSc and the molecular 
weight of the non-glycosylated form of the PrPSc were 
determined for each. In addition, from five selected sam-
ples (from the goats ZYP13, ZYP19, ZYP21, ZYP27 and 
ZYP30) the long term resistance against PK proteolysis 
was determined over 48 h. For comparative purposes, a 
caprine (ZG01), an ovine (486) and a bovine BSE sample 
(R 8/09) and an ovine classical scrapie isolate (Stdl. 171) 
were characterized in the same manner. The molecular 
weight of the non-glycosylated form of PrPSc was deter-
mined to be between 18.0 and 19.4 kDa for the Cypriot 
caprine scrapie isolates. The ovine scrapie isolate and the 
caprine, ovine and bovine BSE isolates exhibited molecu-
lar weights of 19.2 kDa, 18.8 kDa, 18.7 kDa and 18.5 kDa, 
respectively. Referred to the mean of the four to five inde-
pendent determinations of the molecular weight, only 
a part of the caprine scrapie isolates (n =  12) could be 
differentiated from the caprine, ovine and bovine BSE 
isolates. However, all of the Cypriot samples showed 
a molecular weight of the non-glycosylated form of the 
PrPSc clearly above the internal BSE reference of each 
blot. The difference of the molecular weight of the non-
glycosylated form of the PrPSc between the Cypriot iso-
lates and the scrapie reference did not exceed 0.5  kDa 
(−0.1 to 0.49  kDa). The ovine scrapie isolate (Stdl. 171) 
showed a comparable result (0.29 kDa), whereas molec-
ular weights of the three BSE isolates were more than 
0.5 kDa smaller than those of the internal scrapie refer-
ence (−0.67 to −0.56 kDa) (Figure 2).
The P4/L42 antibody binding ratio of the Cypriot iso-
lates ranged between 0.69 and 1.76 and thus indicated a 
clear scrapie-like parameter. In a comparable manner, the 
ovine scrapie isolate (Stdl. 171) showed an antibody bind-
ing ratio of 1.43. For the caprine, ovine and bovine BSE 
isolates, however, distinct different ratio values of 0.16, 
0.16 and 0.03 were determined (Figure 2).
The ratio of the di-glycosylated to the mono-glyco-
sylated form of the PrPSc ranged between 43 and 52%:26 
and 32% for the goat samples, meanwhile for the ovine 
scrapie sample the ratio was 46:30%. In contrast, the BSE 
isolates showed a more dominant di-glycosylated form of 
the PrPSc with ratios of 62:25% for the caprine, 59:26% for 
the ovine and 61:25% for the bovine BSE sample, respec-
tively (Figure 3). Interestingly, eight of the caprine scrapie 
isolates showed a percentage of the di-glycosylated form 
of the PrPSc of >50% (ID ZYP13, ZYP17, ZYP19, ZYP25, 
ZYP27, ZYP29, ZYP30 and ZYP33).
In sum, applying the FLI-test, the Cypriot caprine iso-
lates as well as the ovine scrapie isolate (Stdl. 171) clearly 
showed scrapie-like biochemical characteristics and BSE 
could be excluded for the former isolates without any 
exception. Though eight samples showed a portion of the 
di-glycosylated form of the PrPSc higher than 50%, which 
points to BSE-like characteristics, the other two param-
eters (difference of molecular weight of the non-glyco-
sylated form of the PrPSc to the internal scrapie reference 
and P4/L42 antibody binding ratio) clearly ascertain scra-
pie for these isolates.
Figure 2 Discriminatory immunoblot of goats with PrPSc accumulation in the brain stem. Antibody‑binding ratios P4/L42 and the differ‑
ences of the molecular weights of proteinase K treated, unglycosylated PrPSc bands/form in contrast to the molecular weight of the sheep scrapie 
control are shown of bovine (R8/09), ovine (486) and caprine (ZG01) BSE, of ovine scrapie (Stdl. 171) and all Cypriot caprine scrapie samples. P4/
L42 ratios were calculated as the intensity of the signal strength from P4 versus L42 gained from Western blot.  Y‑axis: dark grey, P4/L42 antibody 
binding ratio (AE = arbitrary unit), data obtained by two gel runs;  light grey, difference molecular weight of the un‑glycosylated form of the PrPSc 
sample and scrapie control (kDa), data obtained by four to five gel runs.
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Those goats, showing a percentage of the di-glyco-
sylated form of the PrPSc higher than 50.0%, all of them 
belonged to the I142N146R151R154R211Q222 wild type geno-
type coming from neighboring herds. At the same time, 
goats from the same (herds G, H, K, M and O) and neigh-
boring herds (e.g. herds F and P) were tested scrapie pos-
itive showing clearly scrapie-like characteristics for this 
parameter (Table 1).
Nevertheless, BSE-like characteristics were verified for 
all control BSE samples of goat, sheep and cattle (ZG 01, 
468 and R 8/09), which all fulfil the three criteria of the 
FLI-test [49].
In addition, the PK resistance was determined for five 
selected Cypriot goat samples and the ovine and caprine 
BSE samples. Four of the selected samples revealed in the 
FLI-test a glycosylation pattern with >50.0% of the digly-
cosylated form of the PrPSc and the one remaining sample 
(ZYP21) showed typical scrapie-like parameters in the 
FLI-test as exhibited by most of the Cypriot scrapie iso-
lates. All the five Cypriot scrapie isolates (ZYP13, ZYP19, 
ZYP21, ZYP27 and ZYP30) tended to a lower protein-
ase K (PK) resistance over a 48 h period than the ovine 
(486) and caprine (ZG01) BSE reference samples (Fig-
ure 4). After 6, 24 and 48 h, 61–72%, 33–42% and 20–28% 
of the PrPSc of the scrapie isolates remained undigested 
compared to 75–79%, 53–63% and 33–39% of the non-
digested BSE isolates (Figure  5). Thus the caprine BSE 
isolate was slightly more resistant against PK digestion.
Histological and immunohistochemical results
All the 25 goats with a positive reactive Biorad TeSeE 
rapid test result exhibited in the obex region distinct 
signs of a spongiform encephalopathy and a clear PrPSc 
accumulation. For histological and immunohistochemi-
cal examinations six regions of the obex region like the 
dorsal motor nucleus of the vagus nerve (DMNV), the 
nucleus of the solitary tract, cuneate nucleus, hypoglos-
sal nucleus, spinal tract nucleus of the trigeminal nerve 
and olivary nuclei were evaluated. Nine of the animals 
showed mild histopathological alterations which were 
mainly confined to the DMNV, the nucleus of the soli-
tary tract and most prominent in the spinal tract nucleus 
of the trigeminal nerve. Nine goats were affected mod-
erately and seven showed severe histological spongi-
form alterations in most of the brain stem nuclei. 
Referring to all samples, the olivary nuclei were affected 
only sporadically.
About half of the samples (n  =  13) revealed moder-
ate deposits of PrPSc with prominent immunoreactiv-
ity in the DMNV, whereas the other half (n  =  12) was 
severely affected by PrPSc depositions. The hypoglossal 
nucleus, however, was less involved in this process. Using 
C-terminal antibodies, intra-neuronal, intra-glial and 
cell-membrane associated/extra-cellular fine up to coarse 
PrPSc accumulations were detected.
All 25 scrapie-positive animals showed depositions of 
PrPSc at least in one sample of the LRS and/or the celiac 
and mesenteric ganglion complex (CMGC), mostly in a 
moderate up to a severe degree (Figure 6). Two additional 
goats (ZYP37 and ZYP24)—with no detectable PrPSc in 
the brain stem—showed positive staining reactions in 
peripheral samples, only. In both goats mild PrPSc accu-
mulations were detected in the CMGC. ZYP24 showed 
additional PrPSc deposits in different samples of the LRS. 
Overall, PrPSc accumulations were of a clear lesser degree 
as those which were found in the samples of the CMGC 
and LRS of the goats with PrPSc positive brain stem sam-
ples. Not for all goats a complete set of samples was avail-
able. Moreover in some LRS and CMGC samples follicles 
or neurons for the evaluation were missing. An overview 
concerning the immunohistochemical findings in the 
peripheral tissues is given in Tables 1 and 2.
The retropharyngeal lymph node revealed the most 
frequent PrPSc detection in the LRS (24/24), followed by 
spleen (24/25), tonsils (18/20), lymphoid follicles of the 
rectum (22/25) and the nictitating membrane (18/26). 
Intracellular fine to coarse PrPSc deposits were detected 
Figure 3 Discriminatory immunoblot of goats with PrPSc 
accumulation in the brain stem. Glycosylation patterns of the 
25 caprine isolates from Cyprus, the caprine (ZG01), ovine (486) and 
bovine (R8/07) BSE isolates and of the ovine scrapie isolate (Stdl. 
171) are shown in a comparative tri‑plot diagram. On the left axis is 
demonstrated the proportion of the di‑glycosylated, on the right axis 
of the mono‑glycosylated and on the axis below the un‑glycosylated 
form of PrPSc of the overall signal in the western blot. The Cypriot 
samples as well as the ovine scrapie case can be clearly differentiated 
from the BSE samples.
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in tingible body macrophages and lymphocytes as well 
as in follicular dendritic cells of the LRS. The CMGC 
showed also frequent mild up to severe PrPSc detection 
(22/22) with a peri- and intraneuronal staining reaction 
as well as an intracellular accumulation in associated sat-
ellite cells. Multifocally distributed glial cells showed a 
Figure 4 Western blot showing PK resistence of PrPSc from Cypriot goats as compared to BSE controls. Resistance of PrPSc of caprine 
(ZG01) and ovine BSE (486) isolates as well as two Cypriot caprine scrapie isolates (ZYP13, ZYP21) after digestion with proteinase K over 1, 6, 24 and 
48 h and visualization in the Western blot using antibody L42.
Figure 5 Diagram showing PK resistance of PrPSc from Cypriot goats as compared to BSE controls. Proteinase K‑resistance of PrPSc after 
1, 6, 24 and 48 h digestion, showing the higher susceptibility of the different scrapie cases (ZYP13, ZYP19, ZYP21, ZYP27, ZYP30) compared to ovine 
(486) and caprine BSE (ZG01). The signal of the PrPSc in the western blot is shown as a percentage of the overall signal after 1 h (=100%). The data 
are obtained by four gel runs (ZYP21 = three gel runs).
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PrPSc deposition, too (Figure 5A). Intraaxonal PrPSc dep-
ositions were seen rarely.
Furthermore, PrPSc accumulations were also detected 
in the ENS of the rectum (22/26), mostly associated with 
additional depositions in lymphoid follicles. Neurons 
and glial cells of both plexus were affected, but more fre-
quently in the myenteric plexus (21/22) as compared to 
the submucosal plexus (12/22). Additionally placental tis-
sue samples from fifteen ewes were analyzed. In doing so, 
rare intracellular PrPSc depositions were demonstrated in 
trophoblasts and epithelial cells of the cotyledons from 
the goats ZYP21, ZYP26 and ZYP27 (Figure 6). No PrPSc 
accumulation was detectable in kidney (0/24), mammary 
gland (0/23) or uterus (0/23).
Discussion
In this study 42 goats from 20 different flocks showed 
clinical signs suspicious for classical scrapie and were 
culled within the context of a scrapie eradication pro-
gram in Cyprus. The animals were sourced out by local 
veterinarians due to unspecific clinical signs which might 
be indicative for scrapie like alopecia, cachexia and 
ataxia. However, these signs are not specific for scrapie 
and there was no possibility for detailed clinical exami-
nations, which explains the comparable high number of 
negative cases among the animals included in the study. 
Age distribution of the TSE positive goats was hetero-
geneous from two up to 6 years of age (mean 3.8 years), 
which is in accordance with previous reports of classical 
scrapie in goats [12, 20, 52]. The goats were analysed to 
get data on genotypic impact on scrapie susceptibility, 
pathologic pathways of caprine scrapie, and finally to 
differentiate it from BSE infection applying discrimina-
tory tests.
Twenty-five of these goats were tested scrapie positive 
and 17 scrapie negative, based on findings in the brain 
stem samples. In this latter group two goats showed PrPSc 
deposits in peripheral sites only. Most of the 25 scrapie 
positive goats belonged to the I142N146R151R154R211Q222 
wild type genotype and had widespread PrPSc accumu-
lations in samples of the CMGC, in the LRS and in the 
rectal ENS. As an exception, one single goat (ZYP40) had 
peripheral PrPSc depositions, which were restricted to the 
CMGC (mild accumulations), the retropharyngeal lymph 
node and to the rectal ENS (severe accumulations). This 
goat had a R/H polymorphism on codon 154. Addition-
ally two of the 17 scrapie rapid test negative goats had 
PrPSc deposits in peripheral sites only, with PrPSc accu-
mulations in the CMGC (ZYP24, ZYP37, both wild type 
genotypes) and also in the LRS of goat ZYP24.
Nevertheless, in goats with negative PrPSc test results in 
the brain stem a higher variability of genotypes was dem-
onstrated with one goat combining two polymorphisms 
relative to the wild type genotype (ZYP39). Therefore 
reduced susceptibility for scrapie was confirmed for the 
goats of this study showing at least one PRNP polymor-
phism (Fisher’s exact test p  =  0.023) with particularly 
goats showing polymorphisms at codon 146 being sig-
nificantly more frequent TSE negative (Fisher’s exact 
test p  =  0.016). These observations are in accordance 
with previous reports, clearly demonstrating a higher 
resistance of N/D146 and N/S146 PrP gene mutations 
to natural and experimental scrapie and even a com-
plete resistance of homozygous polymorphisms of this 
Figure 6 Immunohistochemical detection of PrPSc in autonomic nervous system and placenta. A Celiac and mesenteric ganglion com‑
plex of a scrapie infected goat (ZYP30) with moderate accumulation of PrPSc. Besides a perineuronal staining reaction, intracellular PrPSc deposits 
can be seen in associated satellite cells (arrows) as well as in multifocal glial cells (arrowheads); mAb 6C2; bar 20 µm; B Mild PrPSc accumulations in 
trophoblasts (*) and epithelial cells (arrow) in placental cotyledons of goat ZYP27. M: maternal parts; F: fetal parts; mAb 6C2, bar 10 µm.
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type [12, 13, 53]. Additionally, cell-free conversion assays 
revealed an inhibitory potential of these genotypic vari-
ants, too [54]. It cannot be disregarded that the amount 
of goats examined in this study does not meet the 
requirements of a representative sample and that only six 
codons of the PRNP were considered, but still the results 
support a breeding strategy focussing on codon 146 to 
control and eradicate classical scrapie from Cyprus [53]. 
Whether there was any influence on TSE susceptibility 
due to the polymorphisms R151H and R154H cannot be 
ruled out in this study, though for the latter protective 
effects have already been described before [10, 12, 16, 
18]. The M/M142 polymorphism was found in a negative 
goat 3 years of age. This is not surprising as mutations at 
codon 142 are associated with a lengthened incubation 
period in experimental inoculations and with increased 
resistance under natural conditions [15, 17, 18].
The present study did not reveal any indication that 
natural BSE occurs in goats of this part of Cyprus. With-
out exception all TSE positive brain samples of 25 goats 
including the ovine scrapie isolate (Stdl. 171) were char-
acterized scrapie-like using the discriminatory FLI-test. 
A BSE case would be only indicated if the glycoform ratio 
for the diglycosylated form of the PrPSc is higher than 
50%, the antibody binding ratio P4/L42 has a lower value 
than 0.4 and the molecular mass of the unglycosylated 
band is more than 0.5  kDa lower as compared to the 
internal scrapie control [49]. Therefore BSE was exclu-
sively determined for the ovine, caprine and bovine BSE 
control samples. Eight caprine scrapie isolates revealed 
some discrepancies in the glycosylation pattern showing 
a diglycosylated form of the PrPSc with more than 50% of 
the overall signal which points to BSE-like characteris-
tics. As all other parameters have clear scrapie-like attrib-
utes, these isolates were considered as classical scrapie, 
too. For scrapie in sheep it is well established that differ-
ences in biochemical and immunohistochemical proper-
ties are indicative for strain diversity in the natural host 
[49, 55–58]. More recently others reported molecular dif-
ferences in goat isolates, too [42, 53, 59]. All eight goats 
are of the same wild type genotype and originate from 
similar or at least contact herds. Therefore an infection of 
these goats with the same strain cannot be excluded, but 
whether the biochemical pattern described here suggests 
similar strain diversity remain to be clarified by mouse 
bioassay [60].
In an additional approach four of the eight isolates with 
discordant biochemical properties and a representative 
sample from the other scrapie isolates as well as ovine 
and caprine BSE samples were analyzed by long-term PK 
digestion over a 48 h period. In doing so, no clear differ-
ences were seen among the caprine scrapie isolates but 
these were clearly less resistant against PK digestion than 
the caprine and ovine BSE isolates. The PK resistance of 
PrPSc was demonstrated to depend on the TSE form [57, 
61–63] and recent studies even showed a differentiation 
of classical scrapie isolates in goats based on the sensitiv-
ity to PK digestion at the N-terminal cleavage site [59]. 
Further studies might show possible species and strain 
derived influences on the PK resistance.
Most of the scrapie positive tested goats exhibited 
widespread accumulations of PrPSc in samples  of the 
CMGC and in the ENS as well as in samples of the LRS, 
most commonly in the retropharyngeal lymph node fol-
lowed from accumulations in spleen, tonsils, lymphoid 
rectal tissue and the nictitating membrane. Similar dis-
tribution patterns of PrPSc were also reported in classical 
scrapie affected goats [42, 43, 46] and sheep [33, 35, 37, 
51, 64], respectively. However, one of the scrapie positive 
goats (ZYP40) revealed besides a moderate accumulation 
of PrPSc in the obex region only severe PrPSc depositions 
in the rectal myenteric plexus and mild accumulations 
in the CMGC. Moreover, a restricted involvement of the 
LRS was noticed in this goat with mild PrPSc accumula-
tions in the retropharyngeal lymph node, only. The goat 
was 4  years old and had a R154H polymorphism of the 
PRNP. In goats the R154H polymorphism was described 
to be associated with a prolonged incubation period and 
also with partially protective effects against classical 
scrapie [10, 12, 16]. Furthermore, a similar pattern was 
observed in Cyprus [53] and [58] reported influences of 
the I142M polymorphism on the PrPSc distribution pat-
tern in samples of the caprine central nervous system, 
LRS and ENS. Thus, concerning goat ZYP40 gene based 
restriction of PrPSc distribution and the prolonged incu-
bation period might be plausible, though our data were 
too limited for a proof. Alternatively this pattern could 
indicate a strain dependent effect. For example in sus-
ceptible sheep with a positive reaction in the brain stem 
a limited involvement of the LRS has also been shown 
in individual animals [51]. Further studies using mouse 
bioassays for strain typing purposes might clarify this 
question.
Moreover, in all scrapie positive goats and one scrapie 
negative goat (ZYP24) at least one sample was available 
for ante-mortem diagnosis (tonsil, RAMALT, nictitat-
ing membrane) and they always exhibited clear-cut PrPSc 
deposits. However it has to be emphasized that the com-
parably high frequency of detectable amounts of PrPSc 
in the RAMALT in our study is in contrast to the results 
reported by others, showing only a limited frequency of 
PrPSc detection in this tissue sample [42]. Additionally, 
one of the scrapie negative goats (ZG 37) showed a mild 
PrPSc accumulation in CMGC only and would have been 
missed by these methods, too. Although a false ante-
mortem diagnostic might happen in individual cases, 
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these diagnostic measures could be helpful to differenti-
ate PrPSc positive goats from clinical suspects as shown 
by others in sheep [64–66].
A less easily accessible sample is the CMGC. It was one 
of the most frequent PrPSc positive samples, even positive 
in an otherwise negative goat. To the best of our knowl-
edge such data was never described in scrapie affected 
goats before. However, [32] described similar findings 
in scrapie affected sheep indicating a similar early neu-
ronal spread of PrPSc from the ENS via the CMGC to the 
central nervous system (CNS) in both species. Thus fur-
ther similarities in caprine and ovine scrapie pathogen-
esis can be consolidated. However, discrepancies in the 
PrPSc distribution pattern between our results and others 
were seen concerning the involvement of the ENS in goat 
scrapie. In our hands most of the clinical affected ani-
mals showed a clear accumulation in neurons and satel-
lite cells of the rectal plexus, a region which is known for 
ovine classical scrapie to be involved at later stages of the 
disease [32]. In contrast goats from the UK classical scra-
pie outbreak [43] showed an only inconsistent accumu-
lation of PrPSc in the ileal ENS, a region which is highly 
involved in early ovine TSE pathogenesis at least in the 
highly scrapie susceptible VRQ/VRQ sheep [32]. Addi-
tionally in contrast to earlier studies where PrPSc deposits 
were detected in the kidney of scrapie affected goats [46] 
and sheep [39] and also in the ovine udder [67], PrPSc was 
not found in the kidneys and in the udder of the goats 
of this study. To which extent these patterns are due to 
the species and genotype of the host, strain diversity and/
or the progress of the disease still needed to be clarified. 
However, in three out of 15 goats mild PrPSc accumula-
tions were found in the fetal (trophoblasts) and maternal 
parts (epithelial cells) of the placental cotyledons. This 
is consistent with other studies in scrapie positive goats 
[68] and sheep [69]. All three she-goats showed wide-
spread PrPSc deposits in samples of the LRS and in the 
obex samples implicating that PrPSc is accumulating in 
placental tissue at a late stage of scrapie pathogenesis. 
In sheep, PrPSc accumulation is assumingly highly influ-
enced by the stage of pregnancy and the fetal PRNP geno-
type [69, 70]. These two parameters were not captured in 
this study preventing to draw further conclusions in this 
item. Nevertheless, it would be of high interest to find 
out whether placental PrPSc distribution correlates with 
the state of pathogenesis, to know the influence which is 
taken by the gestation period and the impact of mater-
nal and fetal PRNP genotype in naturally affected goats 
together. Moreover, the importance of caprine placenta 
for scrapie transmission remains to be further clarified.
In summary, a biochemical and immunohistochemi-
cal characterization of natural goat TSE cases from 
different Cyprus herds was performed. The PrPSc was 
detected in the brain stem of 25 goats and 17 goats pro-
vided a negative result. Two of the latter goats exhib-
ited PrPSc deposits in peripheral tissues only. The PrPSc 
negative goats with assumingly reduced scrapie suscep-
tibility were associated with polymorphisms at codon 
146. The discriminatory FLI-test allowed to proof, that 
all 25 positive brain stem isolates showed clear scrapie-
like characteristics. However, eight isolates revealed 
different glycosylation patterns, which might be indica-
tive for the existence of different scrapie strains. To our 
surprise, goat scrapie isolates showed lower resistance 
to long term PK digestion than caprine and ovine BSE 
samples. This fact was very surprising as ovine scrapie 
was demonstrated to be more resistant to long term PK 
digestion than BSE from sheep and cattle. However, no 
differences were seen between the goat isolates. Fur-
thermore, in most goats, PrPSc accumulations were 
widely distributed within ENS, the LRS and the CMGC. 
Even samples which are accessible for ante mortem 
diagnostics (tonsils, RAMALT, third eye lid) were fre-
quently tested PrPSc positive. However, it must be noted, 
that one goat with a R/H154 polymorphism showed an 
only minor involvement of the LRS. Further, the present 
study confirms the presence of PrPSc in trophoblasts 
and epithelial cells of cotelydons from scrapie-affected 
goats.
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